The @EverBluCapital AM Report provides all-inclusive coverage on 430+ ASX listed companies & sectors, the latest market developments and company news. Written by our Research Team led by award winning analyst, Russell Wright. #Research #Markets
SIGN UP: https://t.co/UKXyiCRqqz

The @EverBluCapital Research Team initiates coverage on @CannPalAT. CPAT-01 is a drug at the forefront of a significant market opportunity worth more than US $1B p.a. #MedicalCannibis #Research #ASX #AnimalHealth
REPORT: https://t.co/suG1E6VQwe

$CPH have signed a commercial agreement with Pharmacare Europe for the marketing + distribution of cannaQIX & other products in the UK. Pharmacare have over 10,000 points of sales in Europe alone #MedicalCannabis #CBD #UK #distribution @CresoPharma
MORE: https://t.co/aoACNCDPXI